IBBQ Among Technology ETFs
End-of-day Nov 16, 2026 · 54 Technology ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.2% | +3.6% | +1.5% | +24.1% | +28.4% | +94.4% | +46.7% | +43.8% |
| Peer average | −2.9% | −3.9% | −7.3% | −10.9% | +3.1% | +4.6% | +69.6% | +21.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$91 of every $1,000 in IBBQ is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.08% | $908.03 | 70K | $11.8M |
| 2 | AMGNAmgen | Healthcare | 8.57% | $856.70 | 24K | $11.1M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.82% | $782.09 | 19K | $10.1M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.25% | $624.62 | 8,481 | $8.1M |
| 5 | MRNAModerna | Healthcare | 5.77% | $576.69 | 33K | $7.5M |
| 6 | BIIBBiogen | Healthcare | 2.42% | $242.11 | 12K | $3.1M |
| 7 | RVMDRevolution Medicines | Healthcare | 2.39% | $238.78 | 18K | $3.1M |
| 8 | ILMNIllumina | Healthcare | 2.02% | $202.33 | 13K | $2.6M |
| 9 | RPRXRoyalty Pharma | Healthcare | 2.00% | $199.67 | 37K | $2.6M |
| 10 | ROIVRoivant Sciences | Healthcare | 1.85% | $184.53 | 61K | $2.4M |
| 11 | INSMInsmed | Healthcare | 1.71% | $170.93 | 18K | $2.2M |
| 12 | ARGNFArgenx SE | — | 1.69% | $168.87 | 2,282 | $2.2M |
| 13 | UTHRUnited Therapeutics | Healthcare | 1.64% | $164.23 | 3,604 | $2.1M |
| 14 | INCYIncyte | Healthcare | 1.59% | $158.72 | 17K | $2.1M |
| 15 | VTRSViatris | Healthcare | 1.55% | $154.62 | 96K | $2.0M |
of the $355B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.08% |
| 2 | AMGN | Amgen | 8.57% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.82% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.25% |
| 5 | MRNA | Moderna | 5.77% |
| 6 | BIIB | Biogen | 2.42% |
| 7 | RVMD | Revolution Medicines | 2.39% |
| 8 | ILMN | Illumina | 2.02% |
| 9 | RPRX | Royalty Pharma | 2.00% |
| 10 | ROIV | Roivant Sciences | 1.85% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.23 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0342 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0361 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0906 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0958 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0287 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0402 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0619 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0894 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0506 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0435 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0526 |